ACCURAY INC (ARAY) Stock Fundamental Analysis
USA - NASDAQ:ARAY - US0043971052 - Common Stock
1.55 USD
-0.02 (-1.27%)
1.57 USD
+0.02 (+1.29%)
Taking everything into account, ARAY scores 2 out of 10 in our fundamental rating. ARAY was compared to 189 industry peers in the Health Care Equipment & Supplies industry. ARAY has a bad profitability rating. Also its financial health evaluation is rather negative. ARAY is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ARAY has reported negative net income.
In the past year ARAY had a positive cash flow from operations.
ARAY had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARAY reported negative operating cash flow in multiple years.
1.2 Ratios
ARAY has a Return On Assets of -0.34%. This is in the better half of the industry: ARAY outperforms 71.43% of its industry peers.
ARAY has a Return On Equity of -1.96%. This is in the better half of the industry: ARAY outperforms 70.90% of its industry peers.
ARAY has a better Return On Invested Capital (2.23%) than 69.84% of its industry peers.
ARAY had an Average Return On Invested Capital over the past 3 years of 1.27%. This is significantly below the industry average of 9.01%.
The last Return On Invested Capital (2.23%) for ARAY is above the 3 year average (1.27%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.34% | ||
| ROE | -1.96% | ||
| ROIC | 2.23% |
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)1.27%
ROIC(5y)2.46%
1.3 Margins
The Operating Margin of ARAY (1.71%) is better than 67.20% of its industry peers.
ARAY's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 32.05%, ARAY is not doing good in the industry: 74.60% of the companies in the same industry are doing better.
ARAY's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.71% | ||
| PM (TTM) | N/A | ||
| GM | 32.05% |
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ARAY is destroying value.
Compared to 1 year ago, ARAY has more shares outstanding
ARAY has more shares outstanding than it did 5 years ago.
ARAY has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.08, we must say that ARAY is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.08, ARAY is in line with its industry, outperforming 42.86% of the companies in the same industry.
ARAY has a Debt/Equity ratio of 1.53. This is a high value indicating a heavy dependency on external financing.
ARAY has a worse Debt to Equity ratio (1.53) than 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.53 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.08 |
ROIC/WACC0.32
WACC6.96%
2.3 Liquidity
ARAY has a Current Ratio of 1.65. This is a normal value and indicates that ARAY is financially healthy and should not expect problems in meeting its short term obligations.
ARAY's Current ratio of 1.65 is on the low side compared to the rest of the industry. ARAY is outperformed by 70.90% of its industry peers.
A Quick Ratio of 0.92 indicates that ARAY may have some problems paying its short term obligations.
ARAY has a Quick ratio of 0.92. This is amonst the worse of the industry: ARAY underperforms 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.65 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
ARAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.88%, which is quite impressive.
Looking at the last year, ARAY shows a small growth in Revenue. The Revenue has grown by 2.68% in the last year.
ARAY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.67% yearly.
EPS 1Y (TTM)81.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.67%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-5.02%
3.2 Future
Based on estimates for the next years, ARAY will show a very strong growth in Earnings Per Share. The EPS will grow by 53.35% on average per year.
ARAY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.27% yearly.
EPS Next Y-23.1%
EPS Next 2Y53.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.49%
Revenue Next 2Y4.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ARAY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ARAY. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
ARAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ARAY is cheaper than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 18.31 |
4.3 Compensation for Growth
ARAY's earnings are expected to grow with 53.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.35%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ARAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.55
-0.02 (-1.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.34%
Inst Owner Change0.22%
Ins Owners1.77%
Ins Owner Change-0.06%
Market Cap174.72M
Revenue(TTM)458.50M
Net Income(TTM)-1591000
Analysts86
Price Target5.61 (261.94%)
Short Float %2.67%
Short Ratio3.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7%
Min EPS beat(2)-94.4%
Max EPS beat(2)80.39%
EPS beat(4)3
Avg EPS beat(4)47.43%
Min EPS beat(4)-94.4%
Max EPS beat(4)178.43%
EPS beat(8)5
Avg EPS beat(8)-28.6%
EPS beat(12)7
Avg EPS beat(12)-48.32%
EPS beat(16)10
Avg EPS beat(16)-30.88%
Revenue beat(2)2
Avg Revenue beat(2)5.19%
Min Revenue beat(2)1.02%
Max Revenue beat(2)9.35%
Revenue beat(4)4
Avg Revenue beat(4)3.91%
Min Revenue beat(4)1.02%
Max Revenue beat(4)9.35%
Revenue beat(8)6
Avg Revenue beat(8)1.77%
Revenue beat(12)8
Avg Revenue beat(12)1.22%
Revenue beat(16)11
Avg Revenue beat(16)2.28%
PT rev (1m)0%
PT rev (3m)29.41%
EPS NQ rev (1m)10%
EPS NQ rev (3m)20%
EPS NY rev (1m)-16.67%
EPS NY rev (3m)67.44%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)-6.6%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)4.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | N/A | ||
| P/OCF | 61.09 | ||
| P/B | 2.15 | ||
| P/tB | 22.57 | ||
| EV/EBITDA | 18.31 |
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.03
OCFY1.64%
SpS4.07
BVpS0.72
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.34% | ||
| ROE | -1.96% | ||
| ROCE | 2.82% | ||
| ROIC | 2.23% | ||
| ROICexc | 2.81% | ||
| ROICexgc | 4.22% | ||
| OM | 1.71% | ||
| PM (TTM) | N/A | ||
| GM | 32.05% | ||
| FCFM | N/A |
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)1.27%
ROIC(5y)2.46%
ROICexc(3y)1.67%
ROICexc(5y)3.78%
ROICexgc(3y)2.44%
ROICexgc(5y)5.66%
ROCE(3y)1.6%
ROCE(5y)3.12%
ROICexgc growth 3Y-8.27%
ROICexgc growth 5Y-9.44%
ROICexc growth 3Y-8.35%
ROICexc growth 5Y-10.56%
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
F-Score6
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.53 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.85 | ||
| Cap/Depr | 69.46% | ||
| Cap/Sales | 0.93% | ||
| Interest Coverage | 0.81 | ||
| Cash Conversion | 20.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.65 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 0.08 |
F-Score6
WACC6.96%
ROIC/WACC0.32
Cap/Depr(3y)136.79%
Cap/Depr(5y)106.47%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.67%
EPS Next Y-23.1%
EPS Next 2Y53.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.68%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-5.02%
Revenue Next Year4.49%
Revenue Next 2Y4.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y153.61%
EBIT growth 3Y-1.09%
EBIT growth 5Y-8.91%
EBIT Next Year308.76%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y90.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.03%
OCF growth 3YN/A
OCF growth 5YN/A
ACCURAY INC / ARAY FAQ
What is the fundamental rating for ARAY stock?
ChartMill assigns a fundamental rating of 2 / 10 to ARAY.
What is the valuation status of ACCURAY INC (ARAY) stock?
ChartMill assigns a valuation rating of 1 / 10 to ACCURAY INC (ARAY). This can be considered as Overvalued.
How profitable is ACCURAY INC (ARAY) stock?
ACCURAY INC (ARAY) has a profitability rating of 3 / 10.
What is the expected EPS growth for ACCURAY INC (ARAY) stock?
The Earnings per Share (EPS) of ACCURAY INC (ARAY) is expected to decline by -23.1% in the next year.